News

Tobias Kurth of the Division of Aging at Brigham and Women's Hospital in Massachusetts, and five associates studied physicians, ages 40 to 84, over a period of 4.9

The development of Posidorm, the company’s melatonin product for insomnia, is now expected to be completed in the fourth quarter of 2009 instead of in the fourth quarter

The Roslin Institute modified the chickens with human genes enabling the birds to lay eggs that can produce anti-cancer drugs. The Institute said the drugs were contained within

This acceptance signifies the start of the review process of the new drug application with a “prescription drug user fee act” goal date set for 30 August 2007.

The agreement is currently with the Commissioners of the Federal Trade Commission for final approval and is expected to be endorsed and finalized during the course of this

November 2006 saw Arrow’s first hepatitis C compound, A-831, enter phase I trials. Both compounds target the novel NS5a protein but have completely different chemical structures and bind

Since the last data sweep was completed in November 2006, the monitoring board advised the company to conduct a further data sweep to bring the survival data current

Peregrine has established the wholly foreign-owned enterprise in Beijing and is one of the latest pharmaceutical companies to tap into the expanding Chinese market. “China therefore represents an

Replicated in four distinct ethnic groups, SORL1 is only the second gene discovered for late-onset Alzheimer’s. APOE, the first gene, was identified in 1993. The researchers describe how